Zhifeng You | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Global Nano Awards

Prof. Zhifeng You | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Professor | Shenzhen University of Advanced Technology | China

Prof. Zhifeng You is an emerging researcher in tissue engineering and regenerative biomaterials, with a strong focus on neural repair, nerve injury regeneration, and diabetic wound healing. His work integrates biomaterials, bioinks, and physical cues to advance translational strategies in regenerative medicine. He has published 27 peer-reviewed research articles, including high-impact reviews in leading materials and biomedical journals, contributing significantly to biomaterials-based neural and tissue repair research. His research output has received 1,129 Google Scholar citations, with an h-index of 15 and an i10-index of 18, reflecting consistent scholarly impact, innovation, and recognition within the global biomedical engineering and regenerative medicine research community.

Citation Metrics (Google Scholar)

1200

1000

800

600

400

200

0

Citations
1129

Documents
27

h-index
15

i10index
18

Citations

Documents

h-index

i10-index

View Scopus Profile  View ORCID Profile  View Google Scholar  View ResearchGate  View Researcher Profile

Featured Publications

Young-Yul Kim | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Global Nano Awards

Prof. Dr. Young-Yul Kim | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Department Of Orthopedics | Catholic University of Korea | South Korea

Prof. Dr. Young-Yul Kim is a highly cited researcher in orthopedic spine surgery and regenerative biomaterials, with 2,505 Google Scholar citations across 111 scholarly documents, reflecting a strong h-index of 24 and i10-index of 52. His research integrates clinical spine science with advanced biomaterials, focusing on intervertebral disc degeneration, spinal disorders, biodegradable magnesium alloys, polymer-based and 3D/4D-printed scaffolds, and bone and cartilage regeneration. He has authored influential journal articles, high-impact reviews, and translational studies published in leading international journals, with several works serving as key references in disc biology, autophagy, necroptosis, and scaffold-based tissue engineering. His contributions extend to funded multidisciplinary research projects, innovation-driven R&D, and patented concepts in biodegradable implants and regenerative platforms. Prof. Dr. Young-Yul Kim has received multiple research awards and recognitions, actively contributes as a reviewer and editorial participant for international journals, and plays a significant role in shaping scientific discourse through conference leadership and invited scholarly activities, demonstrating sustained global research impact and innovation leadership.

Citation Metrics (Google Scholar)

3000

2500

2000

1500

1000

500

0

Citations
2505

Documents
111

h-index
24

i10index
52

Citations

Documents

h-index

i10-index

View Scopus Profile  View ORCID Profile  View Google Scholar  View ResearchGate  View Sci Profiles  View Researcher Profile

Featured Publications

Arthroscopic fixation technique for comminuted, displaced greater tuberosity fracture
– Arthroscopy: The Journal of Arthroscopic & Related Surgery, 2010 | Citations: 126

Zhongtao Zhang | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Global Nano Awards

Prof. Dr. Zhongtao Zhang | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Laboratory Director | The Affiliated Taian City Central Hospital of Qingdao University | China

Prof. Dr. Zhongtao Zhang is an accomplished researcher in pharmaceutics and translational pharmaceutical sciences, with a strong focus on advanced drug delivery systems, nano-enabled therapeutics, and precision medicine approaches. His research integrates natural medicinal chemistry, pharmaceutical engineering, and tumor-targeted intervention strategies to address critical challenges in disease treatment and drug bioavailability. He has authored 26 scholarly documents indexed in Scopus, achieving 673 citations and an h-index of 14, reflecting the growing impact and recognition of his work. His publications appear in high-impact international journals such as ACS Nano, Chemical Engineering Journal, Materials Today Bio, and Analytical Chemistry, contributing significantly to nanomedicine, biomaterials, and pharmaceutical innovation. Prof. Dr. Zhongtao Zhang has led multiple competitive research projects supported by national and regional funding agencies and holds several national invention patents, demonstrating strong translational and innovation outcomes. His research contributions continue to advance pharmaceutics, interdisciplinary nanotechnology applications, and clinically oriented pharmaceutical R&D.

Citation Metrics (Scopus)

800

600

400

200

0

Citations
673

Documents
26

h-index
14

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Sofia Mares Bou | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Global Nano Awards

Ms. Sofia Mares Bou | Nanotechnology in Medicine and Healthcare | Research Excellence Award

PhD Student | Centre for Biomaterials and Tissue Engineering (CBIT) – Universitat Politècnica de València (UPV) | Spain

Ms. Sofia Mares Bou is a biomedical engineer with focused research contributions in biomaterials and tissue engineering, emphasizing translational solutions for drug delivery and regenerative medicine. Her scholarly work includes a peer-reviewed journal article in Polymers on core–shell polyvinyl alcohol electrospun microfibers for controlled drug delivery, reflecting expertise in electrospinning, polymeric biomaterials, and therapeutic release systems. She has also presented nationally recognized research on injectable, biomimetic hydrogels for 3D hepatic culture models and hepatotoxicity assessment, contributing to high-throughput in vitro platforms. Ms. Sofia Mares Bou has participated in competitive, publicly funded R&D projects addressing ocular implants for postoperative drug delivery and bioengineered hydrogels with growth-factor presentation. Her research achievements include an award at a national biomedical engineering congress. With Scopus-indexed publications 2, citations 15, and an h-index of 1, her work demonstrates early but impactful contributions to advanced biomaterials, controlled drug delivery, and tissue regeneration research.

Citation Metrics (Scopus)

20

15

10

5

0

Citations
15

Documents
2

h-index
1

Citations

Documents

h-index

View Scopus Profile   View ORCID Profile   View Sci Profiles

Featured Publications

Fan Liu | Nanobiotechnology | Research Excellence Award

Published on by Global Nano Awards

Ms. Fan Liu | Nanobiotechnology | Research Excellence Award

PhD | The University of Sydney | Australia

Ms. Fan Liu is an emerging researcher specializing in nanomaterials, bioimaging probes, polymer-based scaffolds, and photonic materials, with a strong interdisciplinary focus spanning nanotechnology, biomaterials, cancer diagnostics, and photocatalytic applications. Her research contributions demonstrate a consistent emphasis on designing functional nanostructures for biomedical imaging, therapeutic synergy, tissue engineering, and sustainable photoconversion systems. She has authored multiple peer-reviewed journal articles covering advanced nanosystems for cancer imaging and therapy, including tailored carbon dots for synergistic cancer treatment and nanomaterials for cancer photocatalysis therapy. Her work on dual-modal contrast agents integrating magnetic resonance and fluorescence functionalities has contributed to enhanced diagnostic precision in biomedical imaging. Additionally, she has developed a range of peptide- and polymer-based fluorescent probes with targeted imaging capabilities, enabling improved cancer detection and molecular diagnostics. A substantial part of her research portfolio focuses on 3D-printed biodegradable scaffolds utilizing poly(trimethylene carbonate), poly(ε-caprolactone), hydroxyapatite, and β-tricalcium phosphate composites for bone regeneration and multifunctional biomedical applications. These works highlight innovation in scaffold engineering, material biocompatibility, and the integration of nanomaterials into regenerative technologies. Her contributions to energy-related nanotechnology include the development of ZnS-CdSe@Co/N-C core–shell composites for visible-light CO₂ photoconversion, showcasing her interdisciplinary vision and capability in designing nanocomposites for environmental sustainability. As a corresponding author on several publications, she has demonstrated leadership in guiding research design, execution, and dissemination. Her scholarly output spans high-impact journals such as Dyes and Pigments, Materials Today Sustainability, Nanomaterials, New Journal of Chemistry, Talanta, ChemistrySelect, and Bioorganic Chemistry. Her research achievements reflect strong expertise in fluorescent probe synthesis, nanocomposite fabrication, imaging agent development, photocatalytic nanomaterials, and advanced 3D-printing strategies. She continues to contribute to the advancement of nanotechnology-driven solutions for healthcare, diagnostics, regenerative medicine, and sustainable material innovation.

Profiles: Scopus

Featured Publications

1. Liu, F., Zheng, H., & Huang, J. (2026). Tailoring carbon dots for cancer imaging and synergistic therapy. Dyes and Pigments, 246(1), 113391. https://doi.org/10.1016/j.dyepig.2025.113391

2. Ma, S. H., Jiang, L. X., Yang, W. J., Liu, F., Wang, D., Wang, F., & Huang, J. (2025). Advances of nanomaterials in cancer photocatalysis therapy. Materials Today Sustainability, 29, 101023. https://doi.org/10.1016/j.mtsust.2024.101023

3. Zheng, S.-Y., Tang, W.-Q., Zhang, M., Yan, J.-R., Liu, F., Yan, G.-P., Liang, S.-C., & Wang, Y.-F. (2022). Dual-modal polypeptide-containing contrast agents for magnetic resonance / fluorescence imaging. Bioorganic Chemistry, 129, 106161. https://doi.org/10.1016/j.bioorg.2022.106161

4. Zheng, S.-Y., Liu, Z.-W., Kang, H.-L., & Liu, F. (2022). 3D-printed scaffolds based on poly(trimethylene carbonate), poly(ε-caprolactone), and β-tricalcium phosphate. International Journal of Bioprinting, 9(1), 641.

5. Zhang, K., Xu, Y., Liu, F., Yan, G.-P., & Guo, S.-W. (2023). Preparation and properties of ZnS–CdSe@Co/N-C core/shell composites for visible light photoconversion of CO₂. New Journal of Chemistry, 47, 12550.

Héctor Javier Sánchez | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Global Nano Awards

Dr. Héctor Javier Sánchez | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Subject Professor | Technological University of Coahuila | Mexico

Dr. Héctor Javier Sánchez is an active materials science researcher whose work centers on the synthesis, characterization, and biomedical integration of magnetic nanomaterials. His contributions span more than a decade and encompass extensive research on ferrite-based nanoparticles engineered for hyperthermia therapy, diagnostic imaging, toxin adsorption, and multifunctional biomedical applications. His publication record includes numerous peer-reviewed articles in high-impact journals such as Ceramics International, Journal of Magnetism and Magnetic Materials, Journal of Materials Science: Materials in Medicine, Colloids and Surfaces A, and Journal of Alloys and Compounds. These works highlight advances in sol-gel synthesis, thermal decomposition, nanoparticle coating strategies, and the evaluation of structural, magnetic, heating, biocompatibility, and hemolysis properties of materials across systems such as Fe-Ga, Mn-Ga, Co-Ga, Mg-Mn, Mg-Zn, Ti-doped ferrites, and Zn-Mg ferrites. Dr. Héctor Javier Sánchez has also contributed to technological development projects focused on magnetic nanoparticle platforms for cancer hyperthermia, supported by innovation and government funding programs. His participation includes producing final technical reports and advancing R&D packages involving Fe-Ga-Co systems and biomedical coating methodologies for enhanced stability and therapeutic performance. His research dissemination extends to numerous international and national conferences, where he has presented over 30 contributions covering nanoparticle synthesis routes, crystallographic behavior, magnetic induction performance, cytotoxicity studies, and polymer–nanoparticle composites for advanced functional applications. He has also co-authored a book chapter published by the American Ceramics Society, addressing next-generation bioceramics and magnetic materials processing. Dr. Héctor Javier Sánchez’s work reflects a strong focus on innovation in nanomagnetism, bioceramics, and advanced materials engineering. With over 312 citations, 15 documents, and an h-index of 10 (Scopus), multiple collaborative projects, and recognized contributions to magnetic hyperthermia research, he continues to advance the frontier of nanotechnology-enabled biomedical solutions.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Reyes-Rodríguez, P. Y., Cortés-Hernández, D. A., Escobedo-Bocardo, J. C., Almanza-Robles, J. M., Sánchez-Fuentes, H. J., Jasso-Terán, A., De León-Prado, L. E., Méndez-Nonell, J., & Hurtado-López, G. F. (2017). Structural and magnetic properties of Mg–Zn ferrites (Mg₁₋ₓZnₓFe₂O₄) prepared by sol–gel method. Journal of Magnetism and Magnetic Materials, 427, 268–271. https://doi.org/10.1016/j.jmmm.2016.10.078

2. Jasso-Terán, R. A., Cortés-Hernández, D. A., Sánchez-Fuentes, H. J., Reyes-Rodríguez, P. Y., de-León-Prado, L. E., Escobedo-Bocardo, J. C., & Almanza-Robles, J. M. (2017). Synthesis, characterization and hemolysis studies of Zn₍₁₋ₓ₎CaₓFe₂O₄ ferrites synthesized by sol–gel for hyperthermia treatment applications. Journal of Magnetism and Magnetic Materials, 427, 241–244. https://doi.org/10.1016/j.jmmm.2016.10.099

3. Sánchez, J., Cortés-Hernández, D. A., Escobedo-Bocardo, J. C., Jasso-Terán, R. A., & Zugasti-Cruz, A. (2014). Bioactive magnetic nanoparticles of Fe–Ga synthesized by sol–gel for their potential use in hyperthermia treatment. Journal of Materials Science: Materials in Medicine, 25(10), 2237–2242. https://doi.org/10.1007/s10856-014-5197-1

4. De-León-Prado, L. E., Cortés-Hernández, D. A., Almanza-Robles, J. M., Escobedo-Bocardo, J. C., Sánchez, J., Reyes-Rodríguez, P. Y., Jasso-Terán, R. A., & Hurtado-López, G. F. (2017). Synthesis and characterization of nanosized MgₓMn₁₋ₓFe₂O₄ ferrites by both sol–gel and thermal decomposition methods. Journal of Magnetism and Magnetic Materials, 427, 230–234. https://doi.org/10.1016/j.jmmm.2016.11.036

5. Sánchez, J., Rodríguez-Reyes, M., Cortés-Hernández, D. A., Ávila-Orta, C. A., & Reyes-Rodríguez, P. Y. (2021). Heating capacity and biocompatibility of Pluronic-coated manganese gallium ferrites for magnetic hyperthermia treatment. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 612, 125986. https://doi.org/10.1016/j.colsurfa.2020.125986

Agbaje Lateef | Nanobiotechnology | Outstanding Scientist Award

Published on by Global Nano Awards

Prof. Agbaje Lateef | Nanobiotechnology | Outstanding Scientist Award

Professor | Ladoke Akintola University of Technology (LAUTECH) | Nigeria

Prof. Agbaje Lateef is a globally recognized scholar in Industrial Microbiology, Biotechnology, and Nanobiotechnology, distinguished for his pioneering contributions to green nanotechnology and microbial valorization. With an exceptional research impact reflected in over 5,201 Scopus citations, 128 documents, 46 h-index, more than 160 peer-reviewed publications, influential book contributions, and multiple editorial roles, he ranks among the top 2% scientists globally (Elsevier–Stanford). His research has significantly advanced biogenic synthesis of metallic and metal-oxide nanoparticles, establishing cost-effective, eco-friendly approaches using microbial systems, agro-wastes, enzymes, and plant-based materials. These innovations contribute to diverse applications spanning biomedicine, environmental remediation, agriculture, water treatment, catalysis, and circular bioeconomy. He has demonstrated impactful findings on nanoparticle-enabled antimicrobial, antioxidant, anticancer, anticoagulant, larvicidal, antidiabetic, and nanofertilizer functions, offering transformative solutions for health, agriculture, and industry. A leading figure in Nigeria’s nanotechnology landscape, Prof. Agbaje Lateef is the Head of the Nanotechnology Research Group (NANO+), which has produced high-impact research outputs and consistently hosted national workshops and conferences since 2017. His scientometric studies have mapped Nigeria’s nanotechnology progress, shaping national visibility and research direction. His scholarly contributions include serving as Lead Editor of the authoritative book Microbial Nanobiotechnology: Principles and Applications (Springer, 2021), and co-editor of Microbiome and Nano-Cross-Talk: Sustainable Agriculture and Beyond (Elsevier, 2024). He has developed novel nanomaterials for wastewater treatment, corrosion inhibition, biomedical applications, and enhanced crop productivity. Prof. Agbaje Lateef’s work is supported by competitive national research grants, enabling breakthroughs in valorization of keratinous wastes, nanobiopesticides, nano-enabled aquaculture, and nanoparticle-mediated disease management. His research recognitions include prestigious awards for scholarly excellence and sustained global impact. He also provides extensive service as reviewer, editorial board member, and contributor to high-impact journals. Prof. Agbaje Lateef stands as a leading voice in advancing sustainable nanobiotechnology and shaping the future of microbial-based nanomaterial innovation.

Profiles: Scopus | ORCID | Google Scholar | ResearchGate | Web of Science | ScholarGPS | Exaly | Research Group Website 

Featured Publications

1. Adelere, I. A., & Lateef, A. (2016). A novel approach to the green synthesis of metallic nanoparticles: The use of agro-wastes, enzymes and pigments. Nanotechnology Reviews, 5(6), 567–587. https://doi.org/10.1515/ntrev-2016-0024

2. Lateef, A., Azeez, M. A., Asafa, T. B., Yekeen, T. A., Akinboro, A., Oladipo, I. C., Azeez, L., Ajibade, S. E., Ojo, S. A., Gueguim-Kana, E. B., & Beukes, L. S. (2016). Biogenic synthesis of silver nanoparticles using a pod extract of Cola nitida: Antibacterial, antioxidant activities and application as a paint additive. Journal of Taibah University for Science, 10(4), 551–562. https://doi.org/10.1016/j.jtusci.2015.10.010

3. Lateef, A., Adelere, I. A., Gueguim-Kana, E. B., Asafa, T. B., & Beukes, L. S. (2015). Green synthesis of silver nanoparticles using keratinase obtained from a strain of Bacillus safensis LAU 13. International Nano Letters, 5(1), 29–35. https://doi.org/10.1007/s40089-014-0133-4

4. Gueguim Kana, E. B., Oloke, J. K., Lateef, A., & Adesiyan, M. O. (2012). Modeling and optimization of biogas production on saw dust and other co-substrates using artificial neural network and genetic algorithm. Renewable Energy, 46, 276–281. https://doi.org/10.1016/j.renene.2012.03.027

5. Lateef, A., Oloke, J. K., Gueguim Kana, E. B., Oyeniyi, S. O., Onifade, O. R., Oyeleye, A. O., Oladosu, O. C., & Oyelami, A. O. (2008). Improving the quality of agro-wastes by solid-state fermentation: Enhanced antioxidant activities and nutritional qualities. Biotechnology Letters, 24, 2369–2374. https://doi.org/10.1007/s10529-008-9795-4

Fatma Yurt | Nanomedicine | Best Researcher Award

Published on by Global Nano Awards

Prof. Dr. Fatma Yurt | Nanomedicine | Best Researcher Award

Ege University | Turkey

Prof. Dr. Fatma Yurt is a Professor at the Institute of Nuclear Sciences, Ege University, İzmir, Türkiye, where she serves as Coordinator of the Nuclear Applications Program and has previously directed the Institute. She earned her B.Sc. in Chemistry and her Ph.D. in Nuclear Sciences, both from Ege University, and has become a leading academic and researcher in radiopharmacy, nuclear medicine, pharmaceutical technology, radiation shielding, photodynamic therapy, and imaging of infections and cancers. Her pioneering work bridges fundamental nuclear sciences with translational medical applications, with a particular focus on radiopharmaceuticals, radionuclide diagnostics, and innovative therapeutic strategies for cancer and other diseases. Prof. Yurt has published 133 documents, which have been cited 1,613 times across 1,208 documents, achieving an h-index of 22, reflecting her strong international research impact. Her recent research has explored multifunctional nanomaterials, targeted drug delivery systems, and hybrid therapeutic-imaging platforms that integrate photothermal, photodynamic, and chemotherapeutic effects, underscoring her interdisciplinary approach to advancing nuclear applications in medicine. She has also contributed significantly to the development of novel radiolabeling techniques, biosensing strategies, and in vitro and in vivo evaluation methods, demonstrating a commitment to both basic and applied science. In addition to her extensive research contributions, she is a dedicated educator and mentor, fostering the next generation of scientists while contributing to academic leadership, curriculum development, and international collaborations at Ege University, ensuring the growth and global recognition of nuclear sciences research in Türkiye.

Profile: Scopus | Orcid

Featured Publications

  • Kaya, G., Tunçel, A., Özel, D., Sert, B., Harputlu, E., Ünlü, C. G., Ocakoglu, K., & Yurt, F. (2025). Fucoidan-functionalized molybdenum carbide nanospheres for combined therapy: Photothermal, photodynamic, and chemotherapeutic effects on triple-negative breast cancer cell lines. International Journal of Biological Macromolecules.

  • Özel, D., & Yurt, F. (2025). Synthesis and characterization of manganese-loaded core-shell SPIONs for dual T1/T2 weighted MR imaging applications in breast cancer. Inorganic Chemistry Communications.

  • Özel, D., Tunçel, A., Kaya, G., Sert, B., Yilmaz, O., Aktas, S., Kolatan, H. E., Gokbayrak, Ö., Ünlü, C. G., & Yurt, F. (2025). Targeted therapy for glioblastoma: Synergistic effects of GO/C-TMZ,@, PmAb and magnetic hyperthermia. ACS Applied Bio Materials.

  • Tunçel, A., Sert, B., Özel, D., Kaya, G., Harputlu, E., Ünlü, C. G., Güleç, S., Yurt, F., & Ocakoglu, K. (2025). Enhanced glioblastoma treatment via carbon-coated perovskite nanohybrid: Synergistic effects of targeted chemotherapy and magnetic hyperthermia. Journal of Drug Delivery Science and Technology.

  • Özel, D., Sarıkahya, N. B., Tunçel, A., Nalbantsoy, A., & Yurt, F. (2025). Preparation and biodistribution of [131I]iodoelmalienoside a, a saponin-based adjuvant, in mice. Journal of Radioanalytical and Nuclear Chemistry.

  • Kaya, G., Tunçel, A., Özel, D., Sert, B., Harputlu, E., Ünlü, C. G., Ocakoglu, K., & Yurt, F. (2025). Assessment of Mo₂C@C@Fuc/Mo₂C-MXene@Fuc hybrid structures: Potential for photothermal and photodynamic applications. Surfaces and Interfaces.

  • Sezgin, E., Camgöz, B., & Yurt, F. (2025). Radiation dosimetry in 68Ga-PSMA PET/CT prostate imaging. Journal of Radioanalytical and Nuclear Chemistry.

  • Sert, B., Kaya, G., Çiçek, S., Harputlu, E., Şimşek, T., Tekgül, A., Ünlü, C. G., Yurt, F., & Ocakoglu, K. (2025). Influence of silane coating and graphene oxide integration on the magnetothermal behaviors of La1-xSrxMnO3 nanoparticles. Journal of Magnetism and Magnetic Materials.

Yi Yao | Nanomedicine | Best Researcher Award

Published on by Global Nano Awards

Prof. Yi Yao | Nanomedicine | Best Researcher Award

Renmin Hospital of Wuhan University | China

Prof. Yi Yao is a distinguished oncologist, Ph.D., Chief Physician, and Director of the Cancer Center at Renmin Hospital of Wuhan University, China, with a career dedicated to advancing cancer treatment and research. He earned his medical degree and doctorate from Wuhan University and received international training as a Visiting Scholar at the German Cancer Research Center, Heidelberg University, and MD Anderson Cancer Center in the United States. His clinical and research interests focus on tumor radiotherapy and the tumor immune microenvironment, with particular emphasis on how irradiation influences tumor biology, radiotherapy efficacy, and radiation-induced lung injury, including the role of fibroblasts and tumor interstitial fibrosis in treatment outcomes. Prof. Yao has secured major research funding from the National Natural Science Foundation of China, the Hubei Natural Science Foundation, and multiple institutional projects, while building collaborations with world-leading cancer research centers in Germany and the United States. He has published extensively in high-impact journals such as Nature Communications, The EMBO Journal, Journal of Clinical Oncology, Cancer Medicine, Histopathology, Nano Letters, and Frontiers in Immunology, in addition to co-editing oncology volumes and holding software copyrights. Recognized with numerous national, provincial, and institutional awards for his contributions to research, clinical practice, and mentorship, Prof. Yao serves on national and provincial oncology committees, is a member of ASCO and ESMO, and continues to mentor doctoral and master’s students, making lasting contributions to oncology education, clinical innovation, and cancer research.

Profile: Orcid

Featured publications

  • Zhang, H., Chen, L., Li, L., Liu, Y., Das, B., Zhai, S., Tan, J., Jiang, Y., Turco, S., Yao, Y., & Frishman, D. (2025). Prediction and analysis of tumor infiltrating lymphocytes across 28 cancers by TILScout using deep learning. NPJ Precision Oncology, 9(1), 76.

  • Dong, Y., Khan, L., & Yao, Y. (2024). Immunological features of EGFR-mutant NSCLC and clinical practice. Journal of the National Cancer Center, 4(4), 289–298.

  • Yi, L., Wen, Y., Xiao, M., Yuan, J., Ke, X., Zhang, X., Khan, L., Song, Q., & Yao, Y. (2024). The proportion of tumour stroma predicts response to immune checkpoint inhibitor plus chemotherapy in stage IIIB–IV NSCLC. Histopathology, 85(2), 295–309.

  • Yao, Y., Shen, Y., Yao, J. C., & Zuo, X. (2024). Editorial: New advancement in tumor microenvironment remodeling and cancer therapy. Frontiers in Cell and Developmental Biology, 12, 1384567.

  • Li, Y., Chen, J., Wang, B., Xu, Z., Wu, C., Ma, J., Song, Q., Geng, Q., Yu, J., Pei, H., & Yao, Y. (2023). FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis. Drug Resistance Updates, 67, 100926.

  • Yao, Y., Chu, Y., & Xu, B. (2019). Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer. Cancer Medicine, 8(2), 554–563.

Dinesh Kumar | Nanobiotechnology | Global Nanotech Impact Award

Published on by Global Nano Awards

Assist. Prof. Dr. Dinesh Kumar | Nanobiotechnology | Global Nanotech Impact Award

Assistant Professor (Nano Science and Nano Technology), at Department of Interdisciplinary Sciences, National Institute of Food Technology Entrepreneurship and Management, Kundli, India.

Dr. Dinesh Kumar is a distinguished scientist with over 15 years of experience in the healthcare and biomedical research industry. His expertise spans various domains, including in-vitro diagnostics, food safety, molecular diagnostics, and quality control. He has made significant contributions to the development of rapid point-of-care diagnostic devices, biosensors, and immunoassays for infectious and non-communicable diseases. Dr. Kumar has a strong background in human research studies, epidemiology, biostatistics, and regulatory policies. He has been actively involved in accreditation processes for ISO 17025, ISO 15189, and ISO 13485 standards. His technical proficiency extends to software tools such as SPSS, Prism GraphPad, ChemDraw, and Sigma Plot, which he uses for data analysis and research. His work has been widely recognized, with multiple scientific publications, conference presentations, and collaborations with international regulatory bodies for CE marking and quality assurance. Passionate about innovation in healthcare, he has developed microfluidic test devices and IVD-grade recombinant proteins and antibodies. His research has significantly contributed to advancements in diagnostics, particularly in tuberculosis, antimicrobial resistance, and biomarker detection. Dr. Kumar continues to drive excellence in biomedical research through his technical expertise, innovative mindset, and dedication to improving global healthcare standards.

Professional Profile:

Education

Dr. Dinesh Kumar holds a Ph.D. in Biomedical Sciences from the prestigious Indian Institute of Technology (IIT) Delhi, where his doctoral research focused on developing immunoassays for detecting prednisolone using horseradish peroxidase and colloidal gold as labels. His research provided valuable insights into rapid, specific, and user-friendly diagnostic techniques. He also completed a Master of Science (M.Sc.) in Biochemistry from V M University, where he built a strong foundation in biochemical analysis and laboratory research. His undergraduate education includes a Bachelor of Science (B.Sc.) in Medical Laboratory Technology from V M University, equipping him with essential laboratory and clinical skills. Additionally, Dr. Kumar earned a Diploma in Medical Laboratory Technology (DMLT) from the Para Medical Board of India, further strengthening his expertise in clinical diagnostics. To expand his knowledge in food safety and quality management, he pursued a Postgraduate Diploma in Food Safety & Quality Management (PGDFSQM) from IGNOU, New Delhi. His multidisciplinary academic background has enabled him to integrate various scientific approaches into his research, particularly in molecular diagnostics and immunology. His educational journey reflects his commitment to continuous learning and his ability to bridge the gap between fundamental research and real-world healthcare applications.

Professional Experience

Dr. Dinesh Kumar has amassed extensive experience across multiple dimensions of the healthcare industry, including diagnostics research, quality control, and regulatory compliance. He has worked on mass-scale production and testing of in-vitro diagnostic (IVD) rapid kits, biochemistry kits, and RT-PCR molecular diagnostic kits. His expertise in diagnostics has played a crucial role in the development of innovative point-of-care testing devices. He has also provided technical support for product development in molecular diagnostics, biochemistry, and immunoassays, offering consultancy services to various healthcare organizations and government facilities. His experience in accreditation processes for ISO 17025 and ISO 15189 highlights his role in ensuring high-quality standards in laboratory testing. Dr. Kumar has also been actively involved in project preparation and implementation for government health facilities, focusing on improving diagnostic capabilities in healthcare institutions. His professional journey is marked by collaborations with international regulatory bodies, including those responsible for CE marking and ISO compliance. With a strong background in biostatistics and epidemiology, he has contributed significantly to the research and development of diagnostic tools for infectious diseases, antimicrobial resistance, and biomarkers for conditions such as cancer, cardiovascular diseases, and nephrology. His technical and managerial expertise makes him a leader in biomedical innovation.

Research Interests

Dr. Dinesh Kumar’s research interests lie at the intersection of biomedical diagnostics, molecular biology, and nanotechnology. He is particularly passionate about the development of rapid and cost-effective point-of-care diagnostic devices for communicable and non-communicable diseases. His work focuses on immunoassays, biosensors, microfluidic test devices, and molecular diagnostics, particularly RT-PCR technology for infectious disease detection. He has a keen interest in antimicrobial resistance research, aiming to develop diagnostic solutions that enable early detection and effective treatment of resistant infections. His expertise extends to the study of biomarkers for chronic diseases, including cancer, cardiovascular diseases, and nephrology. Additionally, Dr. Kumar has been actively involved in quality assurance and regulatory compliance for medical diagnostics, ensuring that innovations meet international standards for safety and efficacy. His research also encompasses bioinformatics and computational biology, utilizing advanced statistical and data analysis techniques to enhance diagnostic accuracy. His interest in nanotechnology is reflected in his work on biosensors and microfluidic platforms, which have the potential to revolutionize healthcare diagnostics. By integrating biotechnology, immunology, and analytical chemistry, Dr. Kumar strives to bridge the gap between research and clinical application, making diagnostic technologies more accessible and efficient for global healthcare systems.

Research Skills

Dr. Dinesh Kumar possesses a diverse range of research skills that make him a valuable asset in biomedical and healthcare research. He has expertise in immunoassay development, including enzyme-linked immunosorbent assay (ELISA) and lateral flow immunoassay (LFIA), which are crucial for rapid diagnostics. His technical skills in molecular diagnostics include RT-PCR, real-time PCR, and nucleic acid amplification techniques, making him proficient in detecting infectious diseases at the molecular level. He has extensive experience in biosensor technology, microfluidics, and point-of-care testing, particularly for tuberculosis, antimicrobial resistance, and biomarker detection. Dr. Kumar is also skilled in biostatistics and epidemiological data analysis, using software such as SPSS, Prism GraphPad, ChemDraw, and Sigma Plot. His background in quality control and regulatory compliance enables him to ensure the accuracy and reliability of diagnostic products. He is proficient in Good Laboratory Practices (GLP), Standard Operating Procedures (SOP) development, and accreditation processes for ISO 17025 and ISO 15189. Additionally, he has expertise in protein chemistry, including the development of IVD-grade recombinant proteins and monoclonal and polyclonal antibodies. His ability to integrate biotechnology with analytical techniques and computational tools makes him a well-rounded researcher dedicated to advancing biomedical science and healthcare solutions.

Awards and Honors

Dr. Dinesh Kumar has been recognized for his contributions to biomedical research and diagnostics through various awards and honors. He has received accolades for his innovative research in point-of-care diagnostics, including best oral presentation awards at international conferences. His contributions to immunoassay development and biosensor technology have earned him recognition from scientific communities and regulatory organizations. His expertise in molecular diagnostics and antimicrobial resistance has also been acknowledged through invitations to speak at prestigious global conferences. Dr. Kumar has played a key role in obtaining CE marking and ISO accreditation for various diagnostic products, demonstrating his impact on regulatory and quality assurance standards. His commitment to research excellence has been reflected in numerous publications in high-impact scientific journals. Additionally, his mentorship and training programs in diagnostics and quality control have contributed to capacity building in the healthcare sector. As a result, he has established himself as a leading expert in biomedical innovation, with a track record of excellence in research, development, and regulatory compliance. His awards and recognitions highlight his dedication to improving healthcare through cutting-edge diagnostic technologies and scientific advancements.

Conclusion

Dr. Dinesh Kumar is a highly accomplished scientist whose research has significantly advanced the field of biomedical diagnostics. His expertise in immunoassays, biosensors, and molecular diagnostics has led to the development of innovative point-of-care testing devices that address critical healthcare challenges. His extensive experience in regulatory compliance and quality control has ensured that his innovations meet international standards, making a tangible impact on the healthcare industry. His strong academic background, technical proficiency, and research skills have positioned him as a leader in diagnostic development. Dr. Kumar’s contributions to antimicrobial resistance research and biomarker detection highlight his commitment to improving early disease diagnosis and treatment outcomes. His work in nanotechnology applications, particularly in biosensor development, further enhances his eligibility for prestigious research awards. Through his dedication to innovation and excellence, Dr. Kumar continues to shape the future of biomedical research, bridging the gap between scientific discovery and clinical application to improve global healthcare.

Publication Top Notes

  • TG Shrivastav, SK Chaube, KP Kariya, PKV Prasad, D Kumar – 14 citations (2013)
  • TG Shrivastav, SK Chaube, KP Kariya, R Singh, D Kumar, D Pandit, … – 11 citations (2011)
  • TG Shrivastav, SK Chaube, PKV Prasad, KP Kariya, D Kumar – 10 citations (2012)
  • TG Shrivastav, SK Chaube, KP Kariya, S Bhanot, R Singh, D Kumar – 10 citations (2010)
  • TG Shrivastav, SK Chaube, KP Kariya, R Singh, D Kumar, P Jain, … – 9 citations (2012)
  • D Kumar, H Singh, TG Shrivastav – 8 citations (2018)
  • TG Shrivastav, SK Chaube, KP Kariya, P Kumari, R Singh, D Kumar – 8 citations (2011)
  • TG Shrivastav, KP Kariya, PKV Prasad, SK Chaube, D Kumar – 7 citations (2014)
  • TG Shrivastav, SK Chaube, KP Kariya, D Kumar, R Singh – 5 citations (2011)